農夫山泉(09633.HK)董事長鍾睒睒蟬聯福布斯中國首富
《福布斯》發布2022中國內地富豪榜,農夫山泉(09633.HK)董事長鍾睒睒再度成為中國首富,身家縮減5%至623億美元。
今年上榜的中國富豪身家合共下跌39%至9,071億美元,創下《福布斯》有紀錄以來的最大跌幅。字節跳動創辦張一鳴仍然位居第二位,財富下跌16.7%至495億美元,寧德時代(300750.SZ)董事長曾毓群位居第三位,身家大跌43.1%至289億美元。
騰訊(00700.HK)創辦人馬化騰及阿里巴巴(09988.HK)創辦人馬雲則排名第四及第五位,身家分別下跌至234億美元及206億美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.